Clinical Trials on Human Immunodeficiency Virus Type in New Zealand
Total 1540 results
-
MacroGenicsNational Institute of Allergy and Infectious Diseases (NIAID); National Institutes... and other collaboratorsActive, not recruitingHuman Immunodeficiency Virus I Infection | Immunodeficiency Virus Type 1, Human | Human Immunodeficiency Virus Type 1United States
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency Virus | Infections, Human Immunodeficiency Virus and HerpesviridaeUnited States
-
Janssen Sciences Ireland UCCompletedImmunodeficiency Virus Type 1, HumanUnited States, France, Poland, United Kingdom, Belgium, Germany, Spain, Canada, Russian Federation, Puerto Rico
-
Albert Einstein College of MedicineNational Institute of Mental Health (NIMH); HIV Center for Clinical & Behavioral...CompletedHuman Immunodeficiency Virus TransmissionUnited States
-
Janssen R&D IrelandCompletedHuman Immunodeficiency Virus Type 1United States, France, United Kingdom, Belgium, Spain, Switzerland, Sweden, Canada, Puerto Rico, Poland
-
RTI InternationalCenters for Disease Control and PreventionCompletedHuman Immunodeficiency Virus (HIV) PositiveUnited States
-
Tibotec Pharmaceuticals, IrelandCompletedHuman Immunodeficiency Virus - Type 1United States, France, United Kingdom, Germany, Taiwan, Spain, Argentina, Chile, Malaysia, Panama, Romania, South Africa, Thailand, Brazil, Puerto Rico, Austria, Hungary, Australia, Guatemala
-
ViiV HealthcareGlaxoSmithKline; ShionogiCompletedInfections, Human Immunodeficiency Virus and HerpesviridaeUnited States
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKlineCompletedInfections, Human Immunodeficiency Virus and HerpesviridaeUnited States
-
ViiV HealthcareGlaxoSmithKline; ShionogiCompletedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKline; ShionogiCompletedHealthy Subjects | Infection, Human Immunodeficiency VirusUnited States
-
Columbia UniversityCompletedHIV (Human Immunodeficiency Virus)United States
-
Tibotec Pharmaceuticals, IrelandCompletedHuman Immunodeficiency Virus Type 1United States, France, United Kingdom, China, Germany, South Africa, Russian Federation, Argentina, Brazil, Puerto Rico, Austria, Thailand, Mexico, Uganda
-
ViiV HealthcareGlaxoSmithKlineWithdrawnInfection, Human Immunodeficiency Virus IUnited States
-
GlaxoSmithKlineShionogiCompletedHealthy Subjects | Infection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareCompletedInfection, Human Immunodeficiency VirusUnited States
-
GlaxoSmithKlineCompleted
-
Gilead SciencesCompletedHepatitis C Virus InfectionNew Zealand
-
ViiV HealthcareJanssen Research and DevelopmentCompletedHuman Immunodeficiency Virus Type 1 (HIV-1)Germany, Spain, United States, Italy, Canada, Argentina, Sweden
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Alios Biopharma Inc.Completed
-
Tibotec, IncTibotec Therapeutics, a Division of Ortho Biotech Products, L.P., USACompletedHuman Immunodeficiency Virus (HIV)United States, Puerto Rico
-
ViiV HealthcareShionogiCompletedInfections, Human Immunodeficiency Virus and HepatitisUnited States
-
ViiV HealthcareGlaxoSmithKline; ShionogiCompletedHIV Infection | Infection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKlineCompletedHIV Infections | Infection, Human Immunodeficiency VirusUnited States
-
Gilead SciencesTerminatedHuman Immunodeficiency Virus Type 1 (HIV-1) InfectionUnited States
-
Gilead SciencesCompleted
-
St Vincent's Hospital, SydneyMerck Sharp & Dohme LLCTerminatedHuman Immunodeficiency Virus (HIV) | HIV Associated Neurocognitive Disorders (HAND)Australia
-
Bruce BrewViiV HealthcareCompletedHuman Immunodeficiency Virus (HIV) | HIV Associated Neurocognitive Disorders (HAND)Australia
-
VaxartCompletedSeasonal Influenza BNew Zealand
-
Merck Sharp & Dohme LLCActive, not recruitingProphylaxis | Human Immunodeficiency Virus Type 1 | HIV-IUnited States, South Africa, Uganda
-
G & W Laboratories Inc.Alquest; SMART Biotech LtdCompletedHepatitis C | Human Immunodeficiency Virus InfectionUnited States
-
Tibotec Pharmaceuticals, IrelandCompletedHIV Infections | HIV-1 | Human Immunodeficiency Virus Type 1United States, Australia, France, United Kingdom, Taiwan, Spain, Argentina, Portugal, Romania, South Africa, Canada, Denmark, Sweden, Netherlands, Brazil, Puerto Rico, Austria, Russian Federation, Thailand, Mexico
-
Enanta Pharmaceuticals, IncTerminatedChronic Hepatitis B Virus InfectionNew Zealand
-
GlaxoSmithKlineCompletedHIV Infections | Infection, Human Immunodeficiency VirusUnited States, Canada
-
ViiV HealthcareGlaxoSmithKline; ShionogiCompletedInfection, Human Immunodeficiency VirusUnited States
-
Enanta Pharmaceuticals, IncNovotech (Australia) Pty LimitedCompletedHepatitis CNew Zealand
-
Columbia UniversityNational Institute of Nursing Research (NINR)CompletedHIV (Human Immunodeficiency Virus) | AIDS (Acquired Immunodeficiency Syndrome)United States
-
AbbVieCompletedHuman Immunodeficiency Virus (HIV)United States, Puerto Rico
-
Assembly BiosciencesCompletedChronic Hepatitis BNew Zealand
-
ViiV HealthcareGlaxoSmithKlineTerminatedInfection, Human Immunodeficiency VirusUnited States, Canada, Italy, Belgium, Romania
-
ViiV HealthcareGlaxoSmithKlineTerminatedInfection, Human Immunodeficiency Virus IUnited States, Canada, Puerto Rico
-
ViiV HealthcareGlaxoSmithKlineCompletedHIV Infections | Infection, Human Immunodeficiency VirusUnited States, Canada
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency Virus IUnited States, Spain, Canada, Russian Federation, Romania, Belgium, South Africa
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency Virus IUnited States, Puerto Rico
-
ViiV HealthcareGlaxoSmithKline; PPDCompletedInfection, Human Immunodeficiency VirusUnited States, Canada, Puerto Rico
-
Novartis PharmaceuticalsTerminated